Skip to main content

Peer Review reports

From: Neoadjuvant FOLFOX 4 versus FOLFOX 4 with Cetuximab versus immediate surgery for high-risk stage II and III colon cancers: a multicentre randomised controlled phase II trial – the PRODIGE 22 - ECKINOXE trial

Original Submission
19 Oct 2014 Submitted Original manuscript
Author responded Author comments
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
19 Jun 2015 Editorially accepted
10 Jul 2015 Article published 10.1186/s12885-015-1507-3

You can find further information about peer review here.

Back to article page